84 drug batches fail quality test, commonly used antacids, diabetes meds among them | India News

New Delhi: 84 batches of specific drugs, including those commonly prescribed Steroids and cholesterol-lowering drugsThe latest inspections conducted by the company found that it was “unstandard quality”. Drug Control Authority Nationwide. CDSCO, the pinnacle responsible for approval of new drugs and clinical trials, issued a warning about this. CDSCO The problem is warned Non-standard quality medicine It is sold monthly in the market.
According to the latest data from December 2024, they discovered that 84 batches of drugs manufactured by various companies were of non-standard quality.
This includes some of the drugs prescribed for common conditions such as acidity, high levels of cholesterol, diabetes, and bacterial infections.
Identification of drug samples as NSQs is based on the failure of the drug samples with any of the specific quality parameters. The obstacles are specific to the batch of medicines tested by the government, officials said. “This action of identifying NSQ and fake drugs is regularly adopted in collaboration with state regulators to ensure that these drugs are identified and removed from the market,” she added.
Recently, CDSCO introduced new guidelines for testing. All drug inspectors said at least 10 samples should be collected per month. 9 samples of drugs and cosmetic/medical samples.
Also, according to new guidelines, drug inspectors should plan their sampling so that samples are transferred to the lab on the same day of sampling.
For rural locations or far away from the office, the guidelines say that samples will be transferred to the laboratory by the next day.